摘要
脊肌萎缩症(SMA)是最常见的遗传性神经退行性疾病,导致婴儿死亡。SMA是由运动神经元1生存基因缺失或突变引起的基因(SMN1),从而导致运动神经元的存活(SMN)蛋白水平降低。SMN蛋白缺乏优先影响α-运动神经元,导致其退化,肢体和躯干的肌肉萎缩之后,死于严重的疾病。最近的研究表明,SMN蛋白的消耗影响其他组织包括骨骼肌、心脏的功能,自主神经和肠神经系统、代谢/内分泌(例如胰腺)、淋巴结、骨和生殖系统。在这篇综述中,我们总结了研究讨论在不同的细胞和组织类型及其在SMA疾病病因的背景下参与SMN蛋白的功能。总之,这些研究表明,SMA是多器官的疾病,这同时表明,真正有效的疾病干预可能需要的SMN蛋白水平修正。
关键词: 基因治疗,运动神经元,神经肌肉疾病,脊髓性肌萎缩,运动神经元存活,治疗学。
Current Molecular Medicine
Title:Spinal Muscular Atrophy: More than a Disease of Motor Neurons?
Volume: 16 Issue: 9
Author(s): L. A. Nash, J. K. Burns, J. Warman Chardon, R. Kothary, R. J. Parks
Affiliation:
关键词: 基因治疗,运动神经元,神经肌肉疾病,脊髓性肌萎缩,运动神经元存活,治疗学。
摘要: Spinal muscular atrophy (SMA) is the most common genetically inherited neurodegenerative disease resulting in infant mortality. SMA is caused by genetic deletion or mutation in the survival of motor neuron 1 (SMN1) gene, which results in reduced levels of the survival of motor neuron (SMN) protein. SMN protein deficiency preferentially affects α- motor neurons, leading to their degeneration and subsequent atrophy of limb and trunk muscles, progressing to death in severe forms of the disease. More recent studies have shown that SMN protein depletion is detrimental to the functioning of other tissues including skeletal muscle, heart, autonomic and enteric nervous systems, metabolic/endocrine (e.g. pancreas), lymphatic, bone and reproductive system. In this review, we summarize studies discussing SMN protein’s function in various cell and tissue types and their involvement in the context of SMA disease etiology. Taken together, these studies indicate that SMA is a multi-organ disease, which suggests that truly effective disease intervention may require body-wide correction of SMN protein levels.
Export Options
About this article
Cite this article as:
L. A. Nash, J. K. Burns, J. Warman Chardon, R. Kothary, R. J. Parks , Spinal Muscular Atrophy: More than a Disease of Motor Neurons?, Current Molecular Medicine 2016; 16 (9) . https://dx.doi.org/10.2174/1566524016666161128113338
DOI https://dx.doi.org/10.2174/1566524016666161128113338 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
Call for Papers in Thematic Issues
Molecular and Cellular Mechanisms in Vertigo / Vestibular Disorders
Vertigo and vestibular diseases are common among middle-aged and older adults, significantly increasing the risk of falls and leading to injuries and disabilities. Despite their prevalence, therapeutic advancements are hindered by a limited understanding of the underlying molecular and cellular mechanisms. This Special Issue is dedicated to bridging this gap ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Autophagy and Cell Death in Caenorhabditis elegans
Current Pharmaceutical Design Cerebrospinal Fluid Flow Dynamics in Multiple Sclerosis Patients through Phase Contrast Magnetic Resonance Imaging
Current Neurovascular Research High Throughput Screening for Neurodegeneration and Complex Disease Phenotypes
Combinatorial Chemistry & High Throughput Screening Revolutionizing Neurological Disorder Treatment: Integrating Innovations in Pharmaceutical Interventions and Advanced Therapeutic Technologies
Current Pharmaceutical Design Histone Deacetylase Inhibitors and Neurodegenerative Disorders: Holding the Promise
Current Pharmaceutical Design AMPK in Neurodegenerative Diseases: Implications and Therapeutic Perspectives
Current Drug Targets Genomic and Epigenomic Instability, Fragile Sites, Schizophrenia and Autism
Current Genomics Role of Mitochondrial Heat-shock Proteins and Immunophilins in Neuro Degenerative Diseases
Current Drug Targets De Novo DNMTs and DNA Methylation: Novel Insights into Disease Pathogenesis and Therapy from Epigenomics
Current Pharmaceutical Design SUMOylation in Neurological Diseases
Current Molecular Medicine C-terminus of Hsp70 Interacting Protein (CHIP) and Neurodegeneration: Lessons from the Bench and Bedside
Current Neuropharmacology Oxidative and Inflammatory Events in Prion Diseases: Can They Be Therapeutic Targets?
Current Aging Science Nano-medicine Improving the Bioavailability of Small Molecules for the Prevention of Neurodegenerative Diseases
Current Pharmaceutical Design Berberine: Pharmacological Features in Health, Disease and Aging
Current Medicinal Chemistry Intracranial MR Dynamics in Clinically Diagnosed Alzheimers Disease: The Emerging Concept of “Pulse Wave Encephalopathy”
Current Alzheimer Research The Fall in Older Adults: Physical and Cognitive Problems
Current Aging Science Therapeutic Strategies for the Treatment of Spinal Muscular Atrophy (SMA) Disease
Current Genomics Defining the Mechanism of Action of 4-Phenylbutyrate to Develop a Small-Molecule-Based Therapy for Alzheimers Disease
Current Medicinal Chemistry Cardiovascular Alterations After Spinal Cord Injury: An Overview
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Molecular Cytogenetics and Cytogenomics of Brain Diseases
Current Genomics